- Filed
- Feb 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jan 31, 2025 | 24.61M sh |
| Long Term Debt | Q3 2025 · Mar 31, 2024 | $497.73M |
| Long Term Debt | Q3 2025 · Dec 31, 2023 | $574.08M |
| Short Term Debt | Q3 2025 · Mar 31, 2024 | $499.31M |
| Short Term Debt | Q3 2025 · Dec 31, 2023 | $472.97M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $142.28M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $153.52M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $905.17M |
| Current Liabilities | Q3 2025 · Dec 31, 2023 | $765.45M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $1.51B |
| Total Liabilities | Q3 2025 · Dec 31, 2023 | $1.44B |
| Current Assets | Q3 2025 · Mar 31, 2024 | $1.31B |
| Current Assets | Q3 2025 · Dec 31, 2023 | $1.26B |
| Total Assets | Q3 2025 · Mar 31, 2024 | $1.66B |
| Total Assets | Q3 2025 · Dec 31, 2023 | $1.6B |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 25M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 25M sh |
| Capex | Q3 2025 · Dec 31, 2023 | $14.35M |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | −$216.83M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2023 | $90.25M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2023 | $136.73M |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $0.15 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $0.51 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $0.15 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $0.51 |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $42.38M |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $116.48M |
| Net Income | Q3 2025 · Dec 31, 2023 | $3.84M |
| Net Income | Q3 2025 · Dec 31, 2023 | $12.73M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $47.76M |
| Operating Income | Q3 2025 · Dec 31, 2023 | $130.47M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $92.55M |
| Gross Profit | Q3 2025 · Dec 31, 2023 | $254.36M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2023 | $437.27M |
| Cost Of Revenue | Q3 2025 · Dec 31, 2023 | $1.38B |